These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3803424)

  • 1. Accidental overdose of pyrimethamine and sulphadoxine for malaria prophylaxis without adverse effects.
    Lindberg A; Bergqvist Y; Rombo L
    Eur J Clin Pharmacol; 1986; 31(2):253-4. PubMed ID: 3803424
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetic aspects of a pyrimethamine combination with sulfanilamides].
    Lur'e AA; Shcherbakov AM; Lue TV; Nguyen TN; Le DD
    Med Parazitol (Mosk); 1986; (4):10-5. PubMed ID: 3531793
    [No Abstract]   [Full Text] [Related]  

  • 3. Fansidar resistant falciparum malaria acquired in South East Asia.
    Black F; Bygbjerg I; Effersøe P; Gomme G; Jepsen S; Jensen GA
    Trans R Soc Trop Med Hyg; 1981; 75(5):715-6. PubMed ID: 7036431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfadoxine-pyrimethamine embryopathy in Wistar rats.
    Uche-Nwachi EO; Caxton-Martins AE
    Kaibogaku Zasshi; 1998 Apr; 73(2):135-9. PubMed ID: 9617079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results.
    Schapira A; Bygbjerg IC; Jepsen S; Flachs H; Bentzon MW
    Am J Trop Med Hyg; 1986 Mar; 35(2):239-45. PubMed ID: 3513641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.
    Hellgren U; Rombo L; Berg B; Carlson J; Wiholm BE
    Br Med J (Clin Res Ed); 1987 Aug; 295(6594):365-6. PubMed ID: 2958104
    [No Abstract]   [Full Text] [Related]  

  • 7. Human maternofoetal distribution of pyrimethamine-sulphadoxine.
    Trenque T; Marx C; Quereux C; Leroux B; Dupouy D; Dorangeon PH; Choisy H; Pinon JM
    Br J Clin Pharmacol; 1998 Feb; 45(2):179-80. PubMed ID: 9491836
    [No Abstract]   [Full Text] [Related]  

  • 8. Problems with pyrimethamine/sulfadoxine malaria prophylaxis.
    Lelijveld J
    Lancet; 1982 Apr; 1(8277):915. PubMed ID: 6122136
    [No Abstract]   [Full Text] [Related]  

  • 9. High-performance liquid chromatographic assay of pyrimethamine, sulfadoxine and its N4-acetyl metabolite in serum and urine after ingestion of Suldox.
    Midskov C
    J Chromatogr; 1984 Jun; 308():217-27. PubMed ID: 6378948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of sulfadoxine-pyrimethamine and of mefloquine during regular long term malaria prophylaxis.
    Hellgren U; Angel VH; Bergqvist Y; Arvidsson A; Forero-Gomez JS; Rombo L
    Trans R Soc Trop Med Hyg; 1990; 84(1):46-9. PubMed ID: 2345926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome due to pyrimethamine/sulfadoxine during presumptive self-therapy of malaria.
    Phillips-Howard PA; Behrens RH; Dunlop J
    Lancet; 1989 Sep; 2(8666):803-4. PubMed ID: 2571042
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis.
    Win K; Thwe Y; Lwin TT; Win K
    Lancet; 1985 Sep; 2(8457):694-5. PubMed ID: 2863679
    [No Abstract]   [Full Text] [Related]  

  • 13. Serious reactions during malaria prophylaxis with pyrimethamine-sulfadoxine.
    Olsen VV; Loft S; Christensen KD
    Lancet; 1982 Oct; 2(8305):994. PubMed ID: 6127497
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects.
    Karbwang J; Bunnag D; Breckenridge AM; Back DJ
    Eur J Clin Pharmacol; 1987; 32(2):173-7. PubMed ID: 3495440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef.
    Weidekamm E; Schwartz DE; Dubach UC; Weber B
    Chemotherapy; 1987; 33(4):259-65. PubMed ID: 3608626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of malaria prophylaxis in peninsular Malaysia using chloroquine and a combination of sulphadoxine and pyrimethamine.
    Ponnampalam JT
    J Trop Med Hyg; 1978 Oct; 81(10):198-203. PubMed ID: 366165
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar).
    Daniel PT; Holzschuh J; Berg PA
    Thorax; 1989 Apr; 44(4):307-9. PubMed ID: 2763233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar).
    Svanbom M; Rombo L; Gustafsson L
    Br Med J (Clin Res Ed); 1984 Jun; 288(6434):1876. PubMed ID: 6428585
    [No Abstract]   [Full Text] [Related]  

  • 19. Fansidar in malaria prophylaxis.
    Bradley DJ; Hall AP; Peters W; Warhurst D
    Br Med J (Clin Res Ed); 1985 Jul; 291(6488):136. PubMed ID: 3926082
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance of mefloquine alone and in combination with sulfadoxine-pyrimethamine in the prophylaxis of malaria.
    Reisinger EC; Horstmann RD; Dietrich M
    Trans R Soc Trop Med Hyg; 1989; 83(4):474-7. PubMed ID: 2694482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.